A friend sent me a tantalizing press release concerning a study run by UCLA and the Buck Institute, which claims that a “Small trial by UCLA and Buck Institute succeeds using ‘systems approach’ to memory disorders.” (Note direct quotes from the press release will appear here in italics.)
Wow, a cure for memory disorder! In amazement, I stop reading.
So has UCLA had the major breakthrough we’ve all been waiting for and were told was years away?
And what is a systems approach?
I start reading again until I understand that what was involved was a “36-point therapeutic program that involves comprehensive diet changes, brain stimulation, exercise, sleep optimization, specific pharmaceuticals and vitamins, and multiple additional steps that affect brain chemistry.” This program was devised by Dr. Dale Bredesen of the UCLA Mary S. Easton Center for Alzheimer’s Disease Research and the Buck Institute for Research on Aging.
The real science involved here sounds controversial and is far beyond my ability to analyze. Most of us have been told that Alzheimer’s is caused by sticky plaque build up in the brain but Dr. Bredesen conducted a study that found “that Alzheimer’s stems from an imbalance in nerve cell signaling.” Therefore Bredesen says that “a broader-based therapeutic approach, rather than a single drug that aims at a single target, may be feasible and potentially more effective for the treatment of cognitive decline due to Alzheimer’s.”
And golly, 90% of those in the USCLA study “displayed subjective or objective improvement in their memories beginning within three to six months.”
A problem is that that there were only ten patients in the study. Having just read Thinking Fast and Slow by Daniel Kahneman, I am hypersensitive to misleading studies in general and studies with overly small pools of participants in particular. Ten patients is a pretty small pool.
Then there are the “patients” themselves as described in the press release:
Patient 1 had two years of progressive memory loss. She was considering quitting her job, which involved analyzing data and writing reports, she got disoriented driving, and she mixed up the names of her pets.
Patient 2 kept forgetting once-familiar faces at work, forgot his gym locker combination and had to have his assistants constantly remind him of his work schedule.
Patient 3’s memory was so bad that she used an iPad to record everything, then forgot her password.
These three patients sound like Ralph at least five years ago, back when we were still joking about his memory slips. Actually they sound a lot like me right now.
Basically the pool was made up of “patients with memory loss associated with Alzheimer’s disease, amnestic mild cognitive impairment or subjective cognitive impairment (in which the patient reports cognitive problems.” No surprise that the “One patient who had been diagnosed with late stage Alzheimer’s did not improve.”
But still, that most did improve is good news.
The bigger problem for me is the breadth and intensity of demands from participants (and those who care for them). Bredesen’s program requirements include:
- eliminating all simple carbohydrates, gluten and processed food from her diet, and eating more vegetables, fruits and non-farmed fish
- meditating twice a day and beginning yoga to reduce stress
- sleeping seven to eight hours per night, up from four to five
- taking melatonin, methylcobalamin, vitamin D3, fish oil and coenzyme Q10 each day
- optimizing oral hygiene using an electric flosser and electric toothbrush
- reinstating hormone replacement therapy, which had previously been discontinued
- fasting for a minimum of 12 hours between dinner and breakfast, and for a minimum of three hours between dinner and bedtime
- exercising for a minimum of 30 minutes, four to six days per week
Bredesen said the program’s downsides are its complexity and that the burden falls on patients and caregivers to follow it. In the study, none of the patients was able to stick to the entire protocol. Their most common complaints were the diet and lifestyle changes, and having to take multiple pills each day.
The good news, though, said Bredesen, are the side effects: “It is noteworthy that the major side effects of this therapeutic system are improved health and an improved body mass index, a stark contrast to the side effects of many drugs.”
Just reading this explanation exhausted me. Call me lazy, call me selfish, but I can’t see Ralph and me signing up for this regimen any time soon.
Obviously alzheimers is a disease of culture and until there are pharmaceutical drugs that will hit all of these areas including for example the areas of your brains that need exercise and sleep etc. and are able to replace the need to do anything, it is going to be difficult to assist people with Alzheimer’s. Luckily, the Dr. that conducted this research is actually researching a combination approach medicine with a pharmaceutical company at this time, so hopefully it will one day be that easy and then you can just go back to drinking your champagne although it may have contraindications with your meds.
LikeLike
Thanks for this information. I imagine all kinds of approaches are going to be tried in the next few years–I realized today, however, that I have never tasted real champagne so if a breakthrough doesn’t occur, I’ll have to dull my brain on brut, cava or prosecco.
LikeLike
I tried to post earlier and then – poof! It was gone. So maybe this will be a duplicate. In any event, I agree that it was a small trial and that a much larger trial would be necessary to confirm that this program works. Following the full program would be a chore, but I already do many of the suggested things (e.g., diet, exercise, sleep, some of the supplements). If I had reason to be confident that this really would work, I’d do it. As for the “champagne treatment,” sadly I read that it is 2-3 glasses a week, not a day. There’s a low-dose levetiracetam (developed originally to treat epilepsy) Phase III clinical trial underway at Johns Hopkins that follows some promising Phase II results that suggested memory improvement in MCI patients. Maybe that will turn out to be useful.
LikeLike
Thanks so much for this information Many of us probably follow parts of the regimen and if you have the motivation to stick to the rest, it frankly might be worth trying. Everyone is at such a different place on the continuum and affected in different ways, that what may work for you may not work for me and vice versa (Frankly two or three glass of champagne a day would be as hard as the UCLA regimen for me but Ralph would love it). The important thing is that there are a lot of very serious scientists and doctors looking for answers.
LikeLiked by 1 person
Can’t even imagine trying to implement all of this – but I like the champagne too. Maybe that’s the “treatment” for me at this point. Thanks, Liza
LikeLike
Goodness, yes, totally exhausting. Thinking back to when dad was at the stage of the people in the trial I know such a regime would never have been be followed. And I can’t see myself adopting such a lifestyle, even if I know I probably should.
However, I rather like the news which has been buzzing here in the UK (maybe with you, too?) that three glasses of champagne a day can prevent Alzheimers. Just hoping cheap Cava might have the same prophylactic properties.
LikeLiked by 1 person
Oh my, I have not heard about the champagne treatment. That is a solution I am definitely enthusiastic to try and I think I still have a box full of the cheap stuff I served at my daughter’s wedding. Of course, three glasses a day might have unexpected consequences in my case.
LikeLiked by 1 person
Maybe we all just end up as alcoholics and pop our clogs before Alzheimer gets us in itsa grip!
LikeLike